Newtyn Management, LLC 13D/13G Filings for Theravance Biopharma, Inc. (TBPH)

Newtyn Management, LLC 13D and 13G filings for Theravance Biopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:05 pm
Purchase		 2024-12-31 13G Theravance Biopharma, Inc.
TBPH		 Newtyn Management, LLC 4,757,403
9.700%		 657,403increase
(+16.03%)		 Filing
2024-08-16
4:05 pm
Purchase		 2024-08-07 13G Theravance Biopharma, Inc.
TBPH		 Newtyn Management, LLC 4,100,000
8.400%		 4,100,000increase
(New Position)		 Filing